Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2012
09/19/2012CN101530495B Method for preparing phellodendron extract by applying membrane filtration technology
09/19/2012CN101389352B Agent for treating or preventing digestive ulcer
09/18/2012USRE43676 Alkyl ether derivatives or salts thereof
09/18/2012US8269040 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
09/18/2012US8268948 Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
09/18/2012US8268873 Inhibitors of IMPDH enzyme
09/18/2012US8268842 Fused ring 4-oxopyrimidine derivative
09/18/2012US8268837 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268830 Method of using diketopiperazines and composition containing them
09/18/2012US8268829 Substituted pyrimidines useful as protein kinase inhibitors
09/18/2012US8268790 Dermatalogical formulations
09/18/2012US8268617 Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs
09/18/2012US8268555 Method for combined sequential agent delivery and electroporation for cell structures and use thereof
09/18/2012US8268362 Insoluble thrombocyte fragments capable of releasing growth factors prepared by freeze drying and subjected to virus partitioning or deactivation
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012US8268308 Means for the diagnosis and therapy of CTCL
09/18/2012US8267982 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
09/18/2012CA2607907C Method for producing indole derivative having piperidine ring
09/18/2012CA2546002C 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
09/18/2012CA2515259C Use of acetylsalicylic acid for the treatment of hemorrhoidal disease
09/18/2012CA2507002C Solid drug for oral use
09/18/2012CA2492855C Myocardial perfusion imaging using a2a receptor agonists
09/18/2012CA2492156C Tablet composition containing kampo medicinal extract and its manufacturing process
09/18/2012CA2490993C Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparations and uses thereof
09/18/2012CA2443302C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
09/18/2012CA2410662C Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
09/18/2012CA2291483C Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
09/18/2012CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
09/18/2012CA2272051C Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
09/18/2012CA2267310C Stomach submucosa derived tissue graft
09/13/2012WO2012122042A2 Peptide linkers for polypeptide compositions and methods for using same
09/13/2012WO2012121361A1 Dispiropyrrolidine derivative
09/13/2012WO2012121314A1 Dipyridylamine derivative
09/13/2012WO2012121168A1 Kinase inhibitor
09/13/2012WO2012121140A1 Growth hormone secretion promoter
09/13/2012WO2012121058A1 Pharmaceutical composition that uses novel peptide that mimics tnf receptor loop peptide containing cross-linked structure
09/13/2012WO2012120044A1 Tfeb variants and uses thereof
09/13/2012WO2012119265A1 NOVEL ESTERS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR DISEASE THERAPIES
09/13/2012US20120232157 Methods of using derivatives of (-)-venlafaxine
09/13/2012US20120232097 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
09/13/2012US20120232059 Modulators of ATP-Binding Cassette Transporters
09/13/2012US20120232028 Bicyclic Compound, Production and Use Thereof
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120230995 Polyspecific binding molecules and uses thereof
09/13/2012US20120230971 Chromosomal modification involving the induction of double-stranded dna cleavage and homologous recombination at the cleavage site
09/13/2012CA2829188A1 Dispiropyrrolidine derivatives
09/13/2012CA2829187A1 Dipyridylamine derivative
09/13/2012CA2828966A1 Peptide linkers for polypeptide compositions and methods for using same
09/13/2012CA2826864A1 Tfeb variants and uses thereof
09/12/2012EP2497475A1 Treatment of laminitis with platelet aggregation inhibitors
09/12/2012EP2497469A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
09/12/2012EP2496582A1 Benzodiazepine bromodomain inhibitor
09/12/2012EP2496580A1 Benzodiazepine bromodomain inhibitor
09/12/2012EP2496568A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof
09/12/2012CN102666500A Seven-membered ring compound and pharmaceutical use therefor
09/12/2012CN102666490A Aminopyridine compound
09/12/2012CN102665760A Primary bile acid and secondary bile acid generation regulator
09/12/2012CN102665750A Nutritional composition beneficial to small intestine
09/12/2012CN102665749A Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
09/12/2012CN102665738A Prophylactic composition for influenza infection
09/12/2012CN102665715A Compositions for treatment of cystic fibrosis and other chronic diseases
09/12/2012CN102665701A Ceramide and collagen synthesis promoter and collagen saccharification inhibitor
09/12/2012CN102665673A Preventing or ameliorating agent for hypersensitivity in sensitive skin
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102659944A IL-18 binding proteins
09/12/2012CN102659938A Glucagon-like-peptide-2 (GLP-2) analogues
09/12/2012CN102659787A Fluoro polyhydroxy pyrrole pyrrolizidine, and preparation method and application thereof
09/12/2012CN102657833A Traditional Chinese medicine combination for treating puerperium fever
09/12/2012CN102657747A Method for extracting and purifying saffron by-product petal and stamen total flavone
09/12/2012CN102657651A Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
09/12/2012CN101760446B Method for preparing monocyte type stem cell and application
09/12/2012CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263567 A lipophilic anthracycline with a pharmaceutically acceptable carrier for topical administration to a body surface and which has a higher lipophilicity than doxorubicin; valrubicin applied to mucous membranes; psoriasis; side effect reduction; not doxorubicin, daunorubicin, epirubicin or idarubicin
09/11/2012US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
09/11/2012US8263346 Nonhuman model animal lacking the ability to control lymphocyte migration
09/11/2012US8263142 From olives; incubating the acidified water until at least 75 percent of oleoeuropein has been converted to hydroxytyrosol; nutraceuticals in tablet, capsule, pill or confection form; antioxidants
09/11/2012US8263128 Solid pharmaceutical dispersions with enhanced bioavailability
09/11/2012US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection
09/11/2012US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
09/11/2012US8263067 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy
09/11/2012US8262054 Furnace mount
09/11/2012CA2374180C Methods and materials for generating sh3 domains with tailored binding properties
09/11/2012CA2326407C Retroviral vectors including modified envelope escort proteins
09/07/2012WO2012118172A1 Drug for improving central functions during pain
09/07/2012WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity
09/07/2012WO2012118124A1 Novel chemokine receptor antagonist
09/07/2012WO2012118042A1 Medicinal agent for inhibiting metastasis of malignant tumor
09/07/2012WO2012117996A1 Gpr119 agonist
09/07/2012WO2012117592A1 Therapeutic agent for hyperthermia
09/07/2012WO2012116410A1 Methods of treating a disease or condition of the central nervous system
09/06/2012US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
09/06/2012US20120226039 N-Phenyl-2-pyrimidine-amine Derivatives
09/06/2012US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
09/06/2012US20120225849 2-Methoxyestradiol (2-ME2) Prodrug with Enhanced Bioavailability for Prophylaxis or Treatment of Cancerous or Non-Cancerous Condition
09/06/2012US20120225826 Transporters Comprising Spaced Arginine Moieties
09/06/2012US20120225482 Mammalian cx3c chemokine antibodies
09/06/2012US20120225141 Substance for restoring normal co-expression and interaction between the lox and nrage proteins
09/06/2012US20120225082 ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 1564